RDR 03785 (MIF Antagonist IV) is a small molecule inhibitor that targets macrophage migration inhibitory factor (MIF) to control its biological activity. It is applied in cell structure research and has been utilized in both in vitro and in vivo studies to investigate inflammatory and autoimmune disease pathways.